← All trials
NCT05329155
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 20, 2022
- Primary completion
- Jan 1, 2024
- Completion date
- Dec 1, 2024
- First posted
- Apr 14, 2022
- Last posted
- Aug 2, 2022
- Enrollment
- 944
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wuhan UniversityLead sponsor
- Chibi City People's HospitalCollaborator
- Wuhan UniversityOverall official - principal investigator
- Wuhan UniversityReponsible party - principal investigator
- Wuhan Central HospitalCollaborator
- Central South UniversityCollaborator
- Ezhou Central HospitalCollaborator
- Huanggang Central HospitalCollaborator
- Hanyang UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Xianning Central HospitalCollaborator
- Jingzhou Central HospitalCollaborator
- Shiyan People's HospitalCollaborator
- Wuhan UniversityOfficial
- Wuhan UniversityCollaborator
- Enshi Tujia and Miao Autonomous Prefecture Central HospitalCollaborator
- People's Hospital Of YichangCollaborator
- Wuhan UniversitySponsor investigator
- Wuhan Puren HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.